Healthpoint Stuck In $90M Medicaid Fraud Suit

Law360, New York (March 26, 2012, 4:39 PM EDT) -- A Massachusetts federal judge on Monday tossed Healthpoint Ltd.’s motion to dismiss charges brought by the U.S. Department of Justice claiming it caused Medicaid to pay $90 million in claims for bedsore ointment Xenaderm despite the drug’s ineligibility for coverage.

Healthpoint had argued that the government has failed to show the company knew it was doing anything wrong, that notices withdrawing U.S. Food and Drug Administration for similar drugs did not apply to Xenaderm and that the government has failed to adequately plead its charges of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States, ex rel v. Actavis Mid-Atlantic, et al


Case Number

1:02-cv-11738

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Judge

Rya W. Zobel

Date Filed

August 29, 2002

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.